Treatment response to sunitinib in imatinib-resistant recurrence of dermatofibrosarcoma protuberans on the capillitium

被引：0

作者：

Mueller, C. ^{[1
]}

Scheib, C. ^{[1
]}

Peller, V. ^{[1
]}

Zillikens, H. ^{[1
]}

Rudolph, V. ^{[1
]}

Leven, A. S. ^{[1
]}

Bauer, S. ^{[2
]}

Pretzell, I. ^{[3
]}

Griewank, K. ^{[1
]}

Sucker, A. ^{[1
]}

Hadaschik, E. ^{[1
]}

Roesch, A. ^{[1
,2
]}

Ugurel, S. ^{[1
]}

Schadendorf, D. ^{[1
,2
]}

Zimmer, L. ^{[1
]}

Livingstone, E. ^{[1
]}

机构：

[1] Univ Klinikum Essen, Dermatol, Essen, Germany

[2] Deutsches Konsortium Translat Krebsforsch DKTK, Essen, Germany

[3] Univ Klinikum Essen, Westdeutsches Tumorzentrum, Essen, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

eP119

引用

页码：99 / 100

页数：2

共 50 条

[21] Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: A case study
Savoia, Paola
Ortoncelli, Michela
Quaglino, Pietro
Bernengo, Maria Grazia
DERMATOLOGIC SURGERY, 2006, 32 (08) : 1097 - 1102
[22] Dermatofibrosarcoma Protuberans (DFSP): Predictors of Recurrence and Response to Neoadjuvant Therapies
Fields, R. C.
Singer, S.
Brennan, M. F.
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S32 - S32
[23] Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection
Michej, W.
VIRCHOWS ARCHIV, 2012, 461 : S228 - S228
[24] The use of imatinib in the treatment of inoperable dermatofibrosarcoma protuberans in the area of the shoulder joint
Huszno, Joanna
Starzyczny-Slota, Danuta
Nowara, Elzbieta
PRZEGLAD DERMATOLOGICZNY, 2014, 101 (03): : 197 - 200
[25] Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection
Rutkowski, P.
Debiec-Rychter, M.
Nowecki, Z. I.
Michej, W.
Symonides, M.
Ptaszynski, K.
Ruka, W.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (03) : 264 - 270
[26] Imatinib Treatment for Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans A Systematic Review
Navarrete-Dechent, Cristian
Mori, Shoko
Barker, Christopher A.
Dickson, Mark A.
Nehal, Kishwer S.
JAMA DERMATOLOGY, 2019, 155 (03) : 361 - 369
[27] Response to sunitinib in imatinib-resistant gastrointestinal stromal tumor patients correlates with KIT and PDGFRA mutation status
不详
PERSONALIZED MEDICINE, 2006, 3 (03) : 229 - 229
[28] Clinical experience with perioperative sunitinib and extensive resection of imatinib-resistant metastatic gist
Raut, C.
Morgan, J.
Quigley, M.
George, S.
Wagner, A.
Demetri, G.
Bertagnolli, M.
ANNALS OF ONCOLOGY, 2007, 18 : VII123 - VII123
[29] Sunitinib in patients with imatinib-resistant gastrointestinal stromal tumor: A single center experience
Sahu, A.
Godbole, S.
Jain, P.
Ghosh, J.
Shrikhande, S.
Ramadwar, M.
Goyal, M.
Gulia, S.
Bajpai, J.
Kembhavi, Y.
Gupta, S.
INDIAN JOURNAL OF CANCER, 2015, 52 (03) : 320 - U91
[30] FRAGILE PATIENT WITH ALL PH IN IMATINIB-RESISTANT EXTRAMEDULAR RECURRENCE
Oliveira, Monteiro P.
Marques, I
Chorao, P.
Carvalhais, I
Trigo, F.
HAEMATOLOGICA, 2020, 105 : 385 - 385

← 1 2 3 4 5 →